Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: A cross-sectional, observational study of Chinese subjects

Journal of Zhejiang University: Science B

Volumn 13, Issue 5, 2012, Pages 372-377

  Hu, Hang ^a   Han, Chun Mao ^a   Hu, Xin Lei ^a   Ye, Wan Lan ^a   Huang, Wen Juan ^a   Smit, Andries J ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Advanced glycation end products (AGEs); Diabetic foot ulcerations; Screening

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; FOOT ULCER; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SKIN AUTOFLUORESCENCE;

AGED; BIOLOGICAL MARKERS; CHINA; CROSS-SECTIONAL STUDIES; DIABETIC FOOT; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN; SPECTROMETRY, FLUORESCENCE;

EID: 84863484586     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1100249     Document Type: Article

References (22)

1. Apelqvist, J., Bakker, K., van Houtum, W. H., Schaper, N. C., 2008. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab. Res. Rev., 24(S1):S181-S187. [doi:10.1002/dmrr.848] (Pubitemid 351802788)
2. Boulton, A. J., Kirsner, R. S., Vileikyte, L., 2004. Clinical practice. Neuropathic diabetic foot ulcers. N. Engl. J. Med., 351(1):48-55. [doi:10.1056/NEJMcp032966] (Pubitemid 38857247)
3. Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865):813-820. [doi:10.1038/414813a] (Pubitemid 34000785)
4. Chabroux, S., Canoui-Poitrine, F., Reffet, S., Mills-Joncour, G., Morelon, E., Colin, C., Thivolet, C., 2010. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab., 36(2):152-157. [doi: 10.1016/j.diabet.2009.11.003]
5. Dorrian, C. A., Cathcart, S., Clausen, J., Shapiro, D., Dominiczak, M. H., 1998. Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol. Biol. (Noisy-le-grand), 44(7):1069-1079.
6. Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K. E., Lyons, T. J., McCance, D. R., Baynes, J. W., 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest., 91(6):2463-2469. [doi:10. 1172/JCI116481] (Pubitemid 23182497)
7. Garrow, A. P., Boulton, A. J., 2006. Vibration perception threshold-a valuable assessment of neural dysfunction in people with diabetes. Diabetes Metab. Res. Rev., 22(5):411-419. [doi:10.1002/dmrr.657] (Pubitemid 44446437)
8. Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., Neil, H. A., 2008. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med., 359(15):1577-1589. [doi:10.1056/NEJMoa0806470]
9. Hoyt, R. E., 2004. Peripheral arterial disease in people with diabetes: response to consensus statement. Diabetes Care, 27(8):2095. [doi:10.2337/ diacare.27.8.2095] (Pubitemid 38989269)
10. Jeffcoate, W. J., Harding, K. G., 2003. Diabetic foot ulcers. Lance, 361(9368):1545-1551. [doi:10.1016/S0140-6736 (03) 13169-8] (Pubitemid 36566350)
11. Lapolla, A., Piarulli, F., Sartore, G., Ceriello, A., Ragazzi, E., Reitano, R., Baccarin, L., Laverda, B., Fedele, D., 2007. Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diabetes Care, 30(3):670-676. [doi:10. 2337/dc06-1508] (Pubitemid 46354351)
12. Liu, Z., Fu, C., Wang, W., Xu, B., 2010. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a cross-sectional hospital based survey in urban China. Health Qual. Life Outcomes, 8(1):62. [doi:10.1186/1477-7525-8-62]
13. Meerwaldt, R., Graaff, R., Oomen, P. H., Links, T. P., Jager, J. J., Alderson, N. L., Thorpe, S. R., Baynes, J. W., Gans, R. O., Smit, A. J., 2004. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia, 47(7):1324-1330. [doi:10.1007/s00125-004-1451-2] (Pubitemid 39093330)
14. Meerwaldt, R., Links, T. P., Graaff, R., Hoogenberg, K., Lefrandt, J. D., Baynes, J. W., Gans, R. O., Smit, A. J., 2005a. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia, 48(8):1637-1644. [doi:10.1007/s00125-005-1828-x] (Pubitemid 41175518)
15. Meerwaldt, R., Hartog, J. W., Graaff, R., Huisman, R. J., Links, T. P., den Hollander, N. C., Thorpe, S. R., Baynes, J. W., Navis, G., Gans, R. O., et al., 2005b. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J. Am. Soc. Nephrol., 16(12):3687-3693. [doi:10.1681/ASN.2005020144] (Pubitemid 46211290)
16. Meerwaldt, R., Lutgers, H. L., Links, T. P., Graaff, R., Baynes, J. W., Gans, R. O., Smit, A. J., 2007. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care, 30(1):107-112. [doi:10.2337/dc06-1391] (Pubitemid 46052507)
17. Meerwaldt, R., van der Vaart, M. G., van Dam, G. M., Tio, R. A., Hillebrands, J. L., Smit, A. J., Zeebregts, C. J., 2008. Clinical relevance of advanced glycation endproducts for vascular surgery. Eur. J. Vasc. Endovasc. Surg., 36(2):125-131. [doi:10.1016/j.ejvs.2008.01.030] (Pubitemid 351952326)
18. Mišur, I., Žarkovic, K., Barada, A., Batelja, L., Milicevic, Z., Turk, Z., 2004. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy. Acta Diabetol., 41(4):158-166. [doi:10.1007/s00592-004-0160-0] (Pubitemid 40174991)
19. Monami, M., Lamanna, C., Gori, F., Bartalucci, F., Marchionni, N., Mannucci, E., 2008. Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res. Clin. Pract., 79(1):56-60. [doi:10.1016/j.diabres.2007. 07.007]
20. Peppa, M., Stavroulakis, P., Raptis, S. A., 2009. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair. Regen., 17(4):461-472. [doi:10. 1111/j.1524-475X.2009.00518.x]
21. Prompers, L., Schaper, N., Apelqvist, J., Edmonds, M., Jude, E., Mauricio, D., Uccioli, L., Urbancic, V., Bakker, K., Holstein, P., et al., 2008. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia, 51(5):747-755. [doi:10.1007/s00125-008-0940- 0]
22. Vierron, E., Halimi, J. M., Giraudeau, B., 2010. Ankle-brachial index and peripheral arterial disease. N. Engl. J. Med., 362(5):471.